Skip to content

Head-Only Draping in Pediatric Tonsillectomy

30-Day Postoperative Infection Rate in Pediatric Tonsillectomy: Head-Drape vs. Full-Body Surgical Draping

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07347301
Enrollment
200
Registered
2026-01-16
Start date
2026-02-02
Completion date
2026-12-01
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infections, Tonsillectomy

Brief summary

This single-center, interventional study will compare 30-day postoperative infection rates in pediatric tonsillectomy performed with either head-only draping or traditional full-body draping. Secondary analyses will evaluate differences in waste production, material and disposal costs, and provider attitudes between the two draping techniques. This study will randomize participants 1:1 to either the head-only draping cohort (intervention) or the full-body draping cohort (control).

Interventions

OTHERFull-Body Surgical Draping

Standard full-body drape.

OTHERHead-Only Surgical Draping

Use of head drape instead of full-body drape.

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Pediatric patients \<18 years at time of surgery. 2. Scheduled for tonsillectomy, with or without adenoidectomy, without any other procedures requiring full-body draping. 3. Ability to complete 30-day outcome assessment (i.e., remain in follow-up or reachable via phone/electronic health record). 4. Parent/guardian able to provide parental permission and consent for both them and their children.

Exclusion criteria

1. Significant deviation from planned surgical technique during case. 2. Pre-existing systemic infection prior to surgery. 3. Known immunodeficiency or current systemic immunosuppressive therapy.

Design outcomes

Primary

MeasureTime frame
30-day postoperative infection rateDay 30 Post Operation

Secondary

MeasureTime frame
Total weight of wasteDay 0 (Day of Operation)
Disposal costsDay 0 (Day of Operation)

Countries

United States

Contacts

CONTACTNeelima Tummala, MD
neelima.tummala@nyulangone.org646-501-7890
PRINCIPAL_INVESTIGATORNeelima Tummala, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026